27660323|t|Safety and efficacy of tranexamic acid in bleeding paediatric trauma patients: a systematic review protocol
27660323|a|Trauma is the leading cause of death among children aged 1-18. Studies indicate that better control of bleeding could potentially prevent 10-20% of trauma -related deaths. The antifibrinolytic agent tranexamic acid (TxA) has shown promise in haemorrhage control in adult trauma patients. However, information on the potential benefits of TxA in children remains sparse. This review proposes to evaluate the current uses, benefits and adverse effects of TxA in the bleeding paediatric trauma population. A structured search of bibliographic databases (eg, MEDLINE, EMBASE, PubMed, CINAHL, Cochrane CENTRAL) has been undertaken to retrieve randomised controlled trials and cohort studies that describe the use of TxA in paediatric trauma patients. To ensure that all relevant data were captured, the search did not contain any restrictions on language or publication time. After deduplication, citations will be screened independently by 2 authors, and selected for inclusion based on prespecified criteria. Data extraction and risk of bias assessment will be performed independently and in duplicate. Meta-analytic methods will be employed wherever appropriate. This study will not involve primary data collection, and formal ethical approval will therefore not be required. The findings of this study will be disseminated through a peer-reviewed publication and at relevant conference meetings. CRD42016038023.
27660323	23	38	tranexamic acid	T103	UMLS:C0040613
27660323	42	50	bleeding	T038	UMLS:C0019080
27660323	51	68	paediatric trauma	T037	UMLS:C3714660
27660323	81	98	systematic review	T170	UMLS:C1955832
27660323	99	107	protocol	T170	UMLS:C0442711
27660323	108	114	Trauma	T037	UMLS:C3714660
27660323	139	144	death	T033	UMLS:C1306577
27660323	211	219	bleeding	T038	UMLS:C0019080
27660323	256	262	trauma	T037	UMLS:C3714660
27660323	272	278	deaths	T033	UMLS:C1306577
27660323	284	306	antifibrinolytic agent	T103	UMLS:C0003304
27660323	307	322	tranexamic acid	T103	UMLS:C0040613
27660323	324	327	TxA	T103	UMLS:C0040613
27660323	350	361	haemorrhage	T038	UMLS:C0019080
27660323	379	385	trauma	T037	UMLS:C3714660
27660323	446	449	TxA	T103	UMLS:C0040613
27660323	483	489	review	T170	UMLS:C0282443
27660323	542	557	adverse effects	T038	UMLS:C0879626
27660323	561	564	TxA	T103	UMLS:C0040613
27660323	572	580	bleeding	T038	UMLS:C0019080
27660323	581	598	paediatric trauma	T037	UMLS:C3714660
27660323	599	609	population	T098	UMLS:C1257890
27660323	634	657	bibliographic databases	T170	UMLS:C0079198
27660323	663	670	MEDLINE	T170	UMLS:C0025141
27660323	672	678	EMBASE	T170	UMLS:C0079198
27660323	680	686	PubMed	T170	UMLS:C1138432
27660323	688	694	CINAHL	T170	UMLS:C0079198
27660323	696	712	Cochrane CENTRAL	T170	UMLS:C0079198
27660323	746	774	randomised controlled trials	T062	UMLS:C0206035
27660323	819	822	TxA	T103	UMLS:C0040613
27660323	826	843	paediatric trauma	T037	UMLS:C3714660
27660323	1000	1009	citations	T170	UMLS:C0552371
27660323	1046	1053	authors	T097	UMLS:C3812881
27660323	1114	1129	Data extraction	T062	UMLS:C1707635
27660323	1147	1157	assessment	T058	UMLS:C0220825
27660323	1208	1229	Meta-analytic methods	T062	UMLS:C0920317
27660323	1305	1320	data collection	T062	UMLS:C0010995
27660323	1417	1429	disseminated	T082	UMLS:C0205221
27660323	1440	1465	peer-reviewed publication	T170	UMLS:C0034036
27660323	1482	1501	conference meetings	T058	UMLS:C0586182